Bayer’s Aspirina, the number one pain relief option in Mexico, is now available for purchase in the United States, bringing a well-known brand to the Hispanic community.
With a deep commitment to Hispanic consumers, Aspirina is poised to provide an accessible and effective solution for pain relief.
As the Hispanic population in the US continues to grow, currently representing 19% of the population and projected to reach 28% by 2060, Bayer Aspirin recognises the importance of connecting with this vibrant community.
The Aspirina pain relief option resonates deeply with cultural values and family traditions of those from Mexican and Latin American descent who have been using it as a long-standing pain relief option.
“Many Hispanic communities still face inadequate access to healthcare and consumer goods. As the fastest-growing demographic group in the US, the Hispanic population presents a unique opportunity for Bayer."
"By adding Aspirina to the US portfolio, which has a strong equity in LATAM, we are placing the consumer at the centre of our strategy."
"Data shows that 70% of Hispanic consumers feel a strong connection to their country of origin, making it essential for brands to honour and reflect this sentiment,” said Mohamed Atef, Global Brand Lead for Aspirin at Bayer.
Many US consumers of Hispanic origin grew up with Bayer’s Aspirina — their parents and grandparents relied on it, instilling trust and nostalgia for the brand.
Because of those deep connections, Aspirina has a 99% awareness rate in Mexico, with 67% of consumers using it regularly.
With this inclusion in the US market, we invite consumers to reconnect with a product that represents reliability, familiarity and their heritage.
Bayer invented modern aspirin 125 years ago, and it’s the most trusted aspirin brand for pain relief in the US.
Many pain-reliever brands have come and gone during the last century, but Bayer Aspirin continues to be one of the most trusted pain brands on the market.